Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from Artemisia glauca

by Alsfouk, A.A, Dehaen, W., Eissa, I.H, Elkaeed, E.B, Ishmuratova, M.Y, Jose, R.A, Metwaly, A.M, Suleimen, R.N, Suleimen, Y.M, Toppet, S.
Published 2022

Structural and functional significance of the amino acid differences Val35Thr, Ser46Ala, Asn65Ser, and Ala94Ser in 3C-like proteinases from SARS-CoV-2 and SARS-CoV

by Denessiouk, K., Denesyuk, A.I, Johnson, M.S, Permyakov, E.A, Permyakov, S.E, Uversky, V.N
Published 2021

Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from Artemisia glauca

by Alsfouk, A.A, Dehaen, W., Eissa, I.H, Elkaeed, E.B, Ishmuratova, M.Y, Jose, R.A, Metwaly, A.M, Suleimen, R.N, Suleimen, Y.M, Toppet, S.
Published 2022

Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro

by Chen, H., Chen, L., Ge, G., Hu, Q., Li, C., Wang, H., Wang, M., Wang, R., Zhang, Q., Zhang, Y., Zhao, Y., Zhu, G.
Published 2021

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2

by Alsaadawe, M., Chen, X., Chen, Z., Disoma, C., Dong, Z., Du, A., Hu, L., Jiang, T., Li, S., Li, S., Li, S., Liu, P., Liu, S., Mo, L., Peng, J., Peng, Y., Razzaq, A., Shen, Y., Xia, Z., Yang, Q., Zhang, Q., Zhang, Y., Zheng, R., Zhou, Y.
Published 2021

Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches

by Cho, K.-H, Choi, P., Ham, J., Kim, T., Lee, J., Park, J.G, Raj, V.
Published 2021